| Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations TF Eleveld, DA Oldridge, V Bernard, J Koster, LC Daage, SJ Diskin, ... Nature genetics 47 (8), 864-871, 2015 | 637 | 2015 |
| Neuroblastoma is composed of two super-enhancer-associated differentiation states T Van Groningen, J Koster, LJ Valentijn, DA Zwijnenburg, N Akogul, ... Nature genetics 49 (8), 1261-1266, 2017 | 598 | 2017 |
| TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors LJ Valentijn, J Koster, DA Zwijnenburg, NE Hasselt, P Van Sluis, ... Nature genetics 47 (12), 1411-1414, 2015 | 484 | 2015 |
| Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors J Wegert, N Ishaque, R Vardapour, C Geörg, Z Gu, M Bieg, B Ziegler, ... Cancer cell 27 (2), 298-311, 2015 | 360 | 2015 |
| An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity C Calandrini, F Schutgens, R Oka, T Margaritis, T Candelli, L Mathijsen, ... Nature communications 11 (1), 1310, 2020 | 313 | 2020 |
| The immune landscape of neuroblastoma: challenges and opportunities for novel therapeutic strategies in pediatric oncology J Wienke, MP Dierselhuis, GAM Tytgat, A Künkele, S Nierkens, ... European journal of cancer 144, 123-150, 2021 | 220 | 2021 |
| Gain of 1q as a prognostic biomarker in Wilms tumors (WTs) treated with preoperative chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 trial: a … T Chagtai, C Zill, L Dainese, J Wegert, S Savola, S Popov, W Mifsud, ... Journal of Clinical Oncology 34 (26), 3195-3203, 2016 | 147 | 2016 |
| PHOX2B Is a Novel and Specific Marker for Minimal Residual Disease Testing in Neuroblastoma J Stutterheim, A Gerritsen, L Zappeij-Kannegieter, I Kleijn, R Dee, L Hooft, ... Journal of clinical oncology 26 (33), 5443-5449, 2008 | 133 | 2008 |
| Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response … SA Burchill, K Beiske, H Shimada, PF Ambros, R Seeger, GAM Tytgat, ... Cancer 123 (7), 1095-1105, 2017 | 121 | 2017 |
| 123I‐MIBG scintigraphy and 18F‐FDG‐PET imaging for diagnosing neuroblastoma G Bleeker, GAM Tytgat, JA Adam, LCM Kremer, L Hooft, EC van Dalen Cochrane Database of Systematic Reviews, 2015 | 115 | 2015 |
| Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers J Stutterheim, A Gerritsen, L Zappeij-Kannegieter, B Yalcin, R Dee, ... Clinical chemistry 55 (7), 1316-1326, 2009 | 109 | 2009 |
| Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients IRN Verly, ABP van Kuilenburg, NGGM Abeling, SMI Goorden, M Fiocco, ... European journal of cancer 72, 235-243, 2017 | 98 | 2017 |
| Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma R Cuperus, R Leen, GAM Tytgat, HN Caron, ABP Van Kuilenburg Cellular and Molecular Life Sciences 67 (5), 807-816, 2010 | 90 | 2010 |
| Nuclear medicine imaging in neuroblastoma: current status and new developments A Samim, GAM Tytgat, G Bleeker, STM Wenker, KLS Chatalic, AJ Poot, ... Journal of Personalized Medicine 11 (4), 270, 2021 | 86 | 2021 |
| Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy J Wienke, LL Visser, WM Kholosy, KM Keller, M Barisa, E Poon, ... Cancer Cell 42 (2), 283-300. e8, 2024 | 85 | 2024 |
| Development of a Real-Time Polymerase Chain Reaction Assay for Prediction of the Uptake of Meta-[131I]iodobenzylguanidine by Neuroblastoma Tumors S Carlin, RJ Mairs, AG McCluskey, DA Tweddle, A Sprigg, C Estlin, ... Clinical cancer research 9 (9), 3338-3344, 2003 | 76 | 2003 |
| The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review R Van Paemel, R Vlug, K De Preter, N Van Roy, F Speleman, L Willems, ... European journal of pediatrics 179 (2), 191-202, 2020 | 73 | 2020 |
| Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle study R Van Paemel, A De Koker, C Vandeputte, L Van Zogchel, T Lammens, ... Epigenetics 16 (2), 196-208, 2021 | 60 | 2021 |
| Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors C Calandrini, SR van Hooff, I Paassen, D Ayyildiz, S Derakhshan, ... Cell reports 36 (8), 2021 | 54 | 2021 |
| Toxicity of upfront 131I-metaiodobenzylguanidine (131I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis G Bleeker, RA Schoot, HN Caron, J De Kraker, CA Hoefnagel, ... European journal of nuclear medicine and molecular imaging 40 (11), 1711-1717, 2013 | 53 | 2013 |
